HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Asako Ota Selected Research

Neoplasms (Cancer)

9/2022Loss of epidermal Langerhans cells in psoriasiform lesions of de novo induced or worsened pre-existing psoriasis following uses of immune checkpoint inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Asako Ota Research Topics

Disease

1Neoplasms (Cancer)
09/2022
1Psoriasis (Pustulosis Palmaris et Plantaris)
09/2022
1Hypersensitivity (Allergy)
10/2019
1Dermatitis
10/2019

Drug/Important Bio-Agent (IBA)

1B7-H1 AntigenIBA
09/2022
1CTLA-4 AntigenIBA
09/2022
1Immune Checkpoint InhibitorsIBA
09/2022
1Monoclonal AntibodiesIBA
09/2022
1AminesIBA
10/2019
1Tinuvin 770IBA
10/2019